-
1
The first cases of using targeted therapy for secondary progressive multiple sclerosis in Russia. Case report
Published 2023-05-01Subjects: Get full text
Article -
2
Clinical Evaluation of Siponimod for the Treatment of Secondary Progressive Multiple Sclerosis: Pathophysiology, Efficacy, Safety, Patient Acceptability and Adherence
Published 2022-05-01Subjects: “…secondary progressive multiple sclerosis…”
Get full text
Article -
3
Recommendations from the Expert Meeting «Secondary progressive multiple sclerosis: unresolved issues and prospects»
Published 2019-12-01Subjects: “…secondary progressive multiple sclerosis…”
Get full text
Article -
4
Optimization of therapy in secondary progressive multiple sclerosis
Published 2024-08-01Subjects: Get full text
Article -
5
Relationship between kappa light chain level and demyelinating lesion localization in secondary progressive multiple sclerosis
Published 2025-12-01Subjects: Get full text
Article -
6
Effect of Rituximab on the cognitive impairment in patients with secondary progressive multiple sclerosis
Published 2022-06-01Subjects: “…secondary progressive multiple sclerosis (spms)…”
Get full text
Article -
7
Clinical Outcome and Volumetric MRI Assessment of Brain and Cervical Spinal Cord Area in Secondary Progressive Multiple Sclerosis Patients Treated with Rituximab: one-year follow-u...
Published 2023-11-01Subjects: “…secondary progressive multiple sclerosis…”
Get full text
Article -
8
-
9
New possibilities of siponimod therapy in patients with secondary progressive multiple sclerosis
Published 2021-02-01Subjects: Get full text
Article -
10
The Factors Associated With Olfactory Dysfunction in Patients with Multiple Sclerosis
Published 2021-01-01Subjects: Get full text
Article -
11
Mitoxantrone in the treatment of multiple sclerosis: a single-center experience
Published 2012-06-01Subjects: Get full text
Article -
12
Advances in clinical diagnosis of secondary progressive multiple sclerosis
Published 2022-12-01Subjects: “…|secondary progressive multiple sclerosis|pathogenesis|clinical diagnosis|leptomeningeal follicle-like structure…”
Get full text
Article -
13
Comparison of medical and social characteristics and quality of life of patients with primary- and secondary-progressive multiple sclerosis
Published 2021-09-01Subjects: “…secondary-progressive multiple sclerosis…”
Get full text
Article -
14
Long-term effectiveness of natalizumab in secondary progressive multiple sclerosis: A propensity-matched study
Published 2024-07-01Subjects: Get full text
Article -
15
BCL3, GBP1, IFI16, and CCR1 as potential brain-derived biomarkers for parietal grey matter lesions in multiple sclerosis
Published 2024-11-01Subjects: “…Secondary progressive multiple sclerosis…”
Get full text
Article -
16
Consensus on early detection of disease progression in patients with multiple sclerosis
Published 2022-07-01Subjects: Get full text
Article -
17
Balance Right in Multiple Sclerosis (BRiMS): a guided self-management programme to reduce falls and improve quality of life, balance and mobility in people with secondary progressi...
Published 2017-07-01Subjects: “…Secondary progressive multiple sclerosis…”
Get full text
Article -
18
Should We Use Clinical Tools to Identify Disease Progression?
Published 2021-01-01Subjects: Get full text
Article -
19
Re-emergence of T lymphocyte-mediated synaptopathy in progressive multiple sclerosis
Published 2024-06-01Subjects: “…secondary progressive multiple sclerosis…”
Get full text
Article -
20
Effect of disease duration on personality type in multiple sclerosis patients and healthy individual
Published 2016-01-01Subjects: Get full text
Article